학술논문
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial
Document Type
Article
Author
Source
In Lancet Oncology September 2014 15(10):1147-1156
Subject
Language
ISSN
1470-2045